Skip to Content
Jump to the top of the page

Investment Banking

Making Sure America Gets Bang for Its Infrastructure Buck

The country’s electrical, water, telecom, and transit systems are facing years of catch-up repair and maintenance needs—and not even a massive infusion of federal dollars can address all of them. Fortunately, a swarm of companies are specializing in cutting-edge methods of gathering and analyzing data to help assess the areas of greatest need, prioritize initiatives, and maximize government funding.

Those methods fall under the category of Infrastructure Asset Intelligence (IAI). Investors are demonstrating growing interest to partner with companies in the space as they leverage technology to provide accurate, accessible information on the location, specifications, status, and condition of existing infrastructure.

Key takeaways:

  • Why the trillions going toward infrastructure revitalization likely aren't enough
  • The need for better information and analysis on existing infrastructure
  • An overview of the IAI landscape, including segments that will be in high demand in the years ahead

This is the second entry in William Blair’s series, “Investing in Infrastructure Services.” If you’d like to learn more and access detailed research on market participants, accelerating investment activity in the space, and important considerations for potential investors, please contact our team or complete the form below.

Contact Us

Eric Bukovac

Delivered to Your Inbox

Stay up-to-date with the latest William Blair news and insights

More News and Insights

  • How Venture Exits to Private Equity Continue to Grow—With Fuel From AI

    Midmarket technology private equity firms and their portfolio companies have become an important exit pathway for VC-backed companies, especially in the AI era.

    Read more
  • William Blair Hires Head of Biopharma Investment Banking, Based in New York

    William Blair announced today the expansion of the firm’s Healthcare team with the addition of Michael Allwin as managing director and head of Biopharma investment banking.

    Read more
  • Primed Has Agreed to be Acquired by Inflexion

    William Blair acted as the exclusive M&A advisor to Primed, a portfolio company of Paragon, on its pending sale to Inflexion. The transaction signed July 2026.

    Read more

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures